Viking Therapeutics, Inc. (VKTX)
30.62
-0.89
(-2.82%)
USD |
NASDAQ |
Mar 06, 09:34
Viking Therapeutics Cash from Investing (TTM) : 341.39M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Eli Lilly & Co. | -10.97B |
| Pfizer Inc. | -1.351B |
| Amgen, Inc. | -1.943B |
| Hims & Hers Health, Inc. | -1.025B |
| Altimmune, Inc. | -- |